Has Blonie Conde received payments from drug or device companies?

Yes. Drug and device makers reported $2,240 in general payments to Blonie Conde across 109 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Blonie Conde did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Blonie Conde come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Blonie Conde

Family · Ledyard, CTNPI 1043076680

Payments from drug & device makers

$2,240in general payments, 2019–2025

Across 109 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$428
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$380
Vanda Pharmaceuticals Inc.$309
Lilly USA, LLC$122
Ardelyx, Inc.$97
Johnson & Johnson$74
plus $829 from 20 others

What the payments were for

Food & beverage$2,240100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	35	$428
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	11	$380
Vanda Pharmaceuticals Inc.	10	$309
Lilly USA, LLC	6	$122
Ardelyx, Inc.	5	$97
Johnson & Johnson	3	$74
Lundbeck LLC	4	$72
Astellas Pharma US Inc	3	$70
Bayer	3	$70
Novo Nordisk	4	$69
AstraZeneca	3	$66
Antares Pharma, Inc.	3	$59
Pfizer	2	$48
Amgen	2	$43
Paratek Pharmaceuticals, Inc.	2	$41
Otsuka America Pharmaceutical, Inc.	2	$39
Neurocrine Biosciences, Inc.	1	$36
Alkermes, Inc.	1	$33
Azurity Pharmaceuticals, Inc.	2	$32
Takeda Pharmaceuticals U.S.A., Inc.	1	$26
Exact Sciences	1	$26
Optinose US, Inc.	1	$25
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$22
Boehringer Ingelheim	1	$21
Gilead	1	$16
Shield Therapeutics Inc	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CAPLYTA$121

How this compares

$2,240 in reported general payments places this provider in the 80th percentile of 1,596 family providers in Connecticut.

See all family providers in Connecticut →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pregabalin	11	$523
Albuterol Sulfate HfaAlbuterol Sulfate	12	$321
Diclofenac Sodium	11	$286
Fluticasone Propionate	13	$168
Gabapentin	16	$130
Methylprednisolone	20	$127
Pantoprazole Sodium	31	$113
Atorvastatin Calcium	20	$92
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	13	$91
Rosuvastatin Calcium	11	$77
Zolpidem Tartrate	12	$69
Ibuprofen	16	$68
Levothyroxine Sodium	12	$65
Montelukast Sodium	11	$50
Amlodipine Besylate	15	$50

Paid to pharmacies, not to this prescriber.

Other family in Ledyard

Elisha ChristiansonWaterbury$371K
Kathryn TierneyNew Britain$140K
Jennifer SilvaSouth Windsor$91K
Carli WillardEnfield$74K
Erin MartinMilford$70K
Dayna GiordanoNew Haven$65K
Diana BytyqiDerby$53K
Farhiya AbdiSouth Windsor$30K
Nicole SandilandsBridgeport$30K
Ralph HirschfeldPutnam$26K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →